Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010

Article  PubMed  PubMed Central  Google Scholar 

Fernandez Rico C, Konate K, Josse E, Nargeot J, Barrère-Lemaire S, Boisguérin P. Therapeutic peptides to treat myocardial ischemia-reperfusion injury. Front Cardiovasc Med. 2022;9:1–20. https://doi.org/10.3389/fcvm.2022.792885

Article  CAS  Google Scholar 

Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618-51. https://doi.org/10.1161/CIR.0000000000000617

Article  PubMed  Google Scholar 

Parks DA, Granger DN. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol. 1986;250(6):G749-53. https://doi.org/10.1152/ajpgi.1986.250.6.G749

Article  CAS  PubMed  Google Scholar 

Hashmi S, Al-Salam S. Acute myocardial infarction and myocardial ischemia-reperfusion injury: a comparison. Int J Clin E Pathol. 2015;8(8):8786–96.

Google Scholar 

Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123(1):92–100. https://doi.org/10.1172/JCI62874

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heusch G. Myocardial ischaemia–reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol. 2020;17(12):773–89. https://doi.org/10.1038/s41569-020-0403-y

Article  PubMed  Google Scholar 

Ibáñez B, Heusch G, Ovize M, Van de Werf F. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015;65(14):1454–71. https://doi.org/10.1016/j.jacc.2015.02.032

Article  PubMed  Google Scholar 

Rout A, Tantry US, Novakovic M, Sukhi A, Gurbel PA. Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction. Expert Opin Pharmacother. 2020;21(15):1851–65. https://doi.org/10.1080/14656566.2020.1787987

Article  CAS  PubMed  Google Scholar 

Kumar K, Singh N, Jaggi AS, Maslov L. Clinical applicability of conditioning techniques in ischemia-reperfusion injury: a review of the literature. Curr Cardiol Rev. 2021;17(3):306–18. https://doi.org/10.2174/1573403X16999200817170619

Article  PubMed  PubMed Central  Google Scholar 

Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124–36. https://doi.org/10.1161/01.CIR.74.5.1124

Article  CAS  PubMed  Google Scholar 

Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285(2):H579-88. https://doi.org/10.1152/ajpheart.01064.2002

Article  CAS  PubMed  Google Scholar 

Kaur K, Singh N, Dhawan RK. Potential role of EphrinA2 receptors in postconditioning induced cardioprotection in rats. Eur J Pharmacol. 2020;883:1–58. https://doi.org/10.1016/j.ejphar.2020.173231

Article  CAS  Google Scholar 

Zhang J, Zhang X. Ischaemic preconditioning-induced serum exosomes protect against myocardial ischaemia/reperfusion injury in rats by activating the PI3K/AKT signalling pathway. Cell Biochemical Funct. 2021;39(2):287–95. https://doi.org/10.1002/cbf.3578

Article  CAS  Google Scholar 

Li G, Chen S, Lu E, Li Y. Ischemic preconditioning improves preservation with cold blood cardioplegia in valve replacement patients. Eur J Cardiothorac Surg. 1999;15(5):653–7. https://doi.org/10.1016/S1010-7940(99)00070-6

Article  CAS  PubMed  Google Scholar 

Madsen JM, Glinge C, Jabbari R, et al. Comparison of effect of ischemic postconditioning on cardiovascular mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention with versus without thrombectomy. Am J Cardiol. 2022;166:18–24. https://doi.org/10.1016/j.amjcard.2021.11.014

Article  PubMed  Google Scholar 

Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic’preconditioning’protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993;87(3):893–9. https://doi.org/10.1161/01.CIR.87.3.893

Article  CAS  PubMed  Google Scholar 

Wu Q, Gui P, Wu J, et al. Effect of limb ischemic preconditioning on myocardial injury in patients undergoing mitral valve replacement surgery–a randomized controlled trial. Circ J. 2011;75(8):1885–9. https://doi.org/10.1253/circj.CJ-10-1130

Article  PubMed  Google Scholar 

Candilio L, Malik A, Ariti C, et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart. 2015;101(3):185–92. https://doi.org/10.1136/heartjnl-2014-306178

Article  PubMed  Google Scholar 

Drury NE, van Doorn C, Woolley RL, et al. The Bilateral Remote Ischaemic Conditioning in Children (BRICC) trial: a two-centre, double-blind, randomised controlled trial in young children undergoing cardiac surgery. medRxiv. 2023:1-34. https://doi.org/10.1101/2023.04.21.23288646

Davidson SM, Selvaraj P, He D, et al. Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis. Basic Res Cardiol. 2013;108:1. https://doi.org/10.1007/s00395-013-0377-6

Article  CAS  Google Scholar 

Wang X, Wang J, Tu T, et al. Remote ischemic postconditioning protects against myocardial ischemia-reperfusion injury by inhibition of the RAGE-HMGB1 pathway. Biomed Res Int. 2018;2018:1–10. https://doi.org/10.1155/2018/4565630

Article  CAS  Google Scholar 

Sawashita Y, Hirata N, Yoshikawa Y, Terada H, Tokinaga Y, Yamakage M. Remote ischemic preconditioning reduces myocardial ischemia–reperfusion injury through unacylated ghrelin-induced activation of the JAK/STAT pathway. Basic Res Cardiol. 2020;115:1–2. https://doi.org/10.1007/s00395-020-0809-z

Article  Google Scholar 

Rohailla S, Clarizia N, Sourour M, et al. Acute, delayed and chronic remote ischemic conditioning is associated with downregulation of mTOR and enhanced autophagy signaling. PLoS One. 2014;9(10):111291. https://doi.org/10.1371/journal.pone.0111291

Article  CAS  Google Scholar 

Deepika Maurya PK. Health benefits of quercetin in age-related diseases. Molecules. 2022;27(8):1–4. https://doi.org/10.3390/molecules27082498

Article  CAS  Google Scholar 

Zhang YM, Zhang ZY, Wang RX. Protective mechanisms of quercetin against myocardial ischemia reperfusion injury. Front Physiol. 2020;11(956):1–12. https://doi.org/10.3389/fphys.2020.00956

Article  Google Scholar 

Yang R, Shen YJ, Chen M, et al. Quercetin attenuates ischemia reperfusion injury by protecting the blood-brain barrier through Sirt1 in MCAO rats. J Asian Nat Prod Res. 2022;24(3):278–89. https://doi.org/10.1080/10286020.2021.1949302

Article  CAS  PubMed  Google Scholar 

Canuto JA, Sampaio TL, Silva ME, et al. Protective effect of quercetin on renal tubular cells and the involvement with the renin-angiotensin-aldosterone axis. Braz Arch Biol Technol. 2022;5(64):1–18. https://doi.org/10.1590/1678-4324-2021210202.

Article  CAS  Google Scholar 

Atef Y, El-Fayoumi HM, Abdel-Mottaleb Y, Mahmoud MF. Quercetin and tin protoporphyrin attenuate hepatic ischemia reperfusion injury: role of HO-1. Naunyn-Schmiedebergs Arch Pharmacol. 2017;390(9):871–81. https://doi.org/10.1007/s00210-017-1389-9.

Article  CAS  PubMed  Google Scholar 

Curgali K, Toth S, Jonecova Z, et al. Quercetin protects jejunal mucosa from experimental intestinal ischemia reperfusion injury by activation of CD68 positive cells. Acta Histochemica. 2018;120(1):28–32. https://doi.org/10.1016/j.acthis.2017.11.001.

Article  CAS  PubMed  Google Scholar 

Liu Y, Song Y, Li S, Mo L. Cardioprotective effect of quercetin against ischemia/reperfusion injury is mediated through NO system and mitochondrial K-ATP channels. Cell J. 2021;23(2):184–90. https://doi.org/10.22074/cellj.2021.7183

Article  PubMed